Pulsatile administration of D1 but not D2 dopamine agonists induces behavioral tolerance in MPTP-treated monkeys
Luquin, M.R.; Guillén, J.; Legarda, I.; Cruz Rodriguez, M.; Del Rio, L.; Dominguez, J.; Martínez-Lage, J.M.
Advances in Neurology 69: 239-244
1996
ISSN/ISBN: 0091-3952 PMID: 8615134 Document Number: 462298
Document emailed within 1 workday
Related Documents
Domino, E.F.; Sheng, J. 1993: Relative potency and efficacy of some dopamine agonists with varying selectivities for D1 and D2 receptors in MPTP-induced hemiparkinsonian monkeys Journal of Pharmacology and Experimental Therapeutics 265(3): 1387-1391Graybiel, A.M.; Moratalla, R.; Quinn, B.; DeLanney, L.E.; Irwin, I.; Langston, J.W. 1993: Early-stage loss of dopamine uptake-site binding in MPTP-treated monkeys Advances in Neurology 60: 34-39
Breese, G.R.; Baumeister, A.A.; McCown, T.J.; Emerick, S.G.; Frye, G.D.; Crotty, K.; Mueller, R.A. 1984: Behavioral differences between neonatal and adult 6-hydroxydopamine-treated rats to dopamine agonists: relevance to neurological symptoms in clinical syndromes with reduced brain dopamine Journal of Pharmacology and Experimental Therapeutics 231(2): 343-354
Woolverton, W.L.; Goldberg, L.I.; Ginos, J.Z. 1984: Intravenous self-administration of dopamine receptor agonists by rhesus monkeys Journal of Pharmacology and Experimental Therapeutics 230(3): 678-683
Blanchet, P.J.; Gomez-Mancilla, B.; Bédard, P.J. 1995: DOPA-induced "peak dose" dyskinesia: clues implicating D2 receptor-mediated mechanisms using dopaminergic agonists in MPTP monkeys Journal of Neural Transmission. Supplementum 45: 103-112
Kleven, M.S.; Koek, W. 1996: Differential effects of direct and indirect dopamine agonists on eye blink rate in cynomolgus monkeys Journal of Pharmacology and Experimental Therapeutics 279(3): 1211-1219
van Harten, P.N.; Loonen, A.J.M. 2006: The restless legs syndrome can be treated with dopamine agonists Nederlands Tijdschrift Voor Geneeskunde 150(52): 2894; Author Reply 2894-5
Aramideh, M.; de Weerd, A.W. 2006: The restless legs syndrome can be treated with dopamine agonists Nederlands Tijdschrift Voor Geneeskunde 150(40): 2173-2177
Braun, G.G.; Bahlmann, F.; Brandl, M.; Knoll, R. 1989: Long term administration of dopamine: is there a development of tolerance? Progress in Clinical and Biological Research 308: 1097-1099
Hamon, M.; Fattaccini, C.M.; Adrien, J.; Gallissot, M.C.; Martin, P.; Gozlan, H. 1988: Alterations of central serotonin and dopamine turnover in rats treated with ipsapirone and other 5-hydroxytryptamine1A agonists with potential anxiolytic properties Journal of Pharmacology and Experimental Therapeutics 246(2): 745-752
Cooper, B.R.; Breese, G.R. 1974: Relationship of catecholamine neural systems to the behavioral alterations produced by 6-hydroxy-dopamine administration into brain Psychopharmacology Bulletin 10(3): 39
Tadori, Y.; Kobayashi, H. 2014: The therapeutic plasma concentrations of antiparkinson dopamine agonists and their in vitro pharmacology at dopamine receptors Nihon Shinkei Seishin Yakurigaku Zasshi 34(5-6): 127-132
Kohli, J.D.; Weder, A.B.; Goldberg, L.I.; Ginos, J.Z. 1980: Structure activity relationships of N-substituted dopamine derivatives as agonists of the dopamine vascular and other cardiovascular receptors Journal of Pharmacology and Experimental Therapeutics 213(2): 370-374
Breese, G.R.; Baumeister, A.; Napier, T.C.; Frye, G.D.; Mueller, R.A. 1985: Evidence that D-1 dopamine receptors contribute to the supersensitive behavioral responses induced by L-dihydroxyphenylalanine in rats treated neonatally with 6-hydroxydopamine Journal of Pharmacology and Experimental Therapeutics 235(2): 287-295
Wagner, G.C.; Ricaurte, G.A.; Johanson, C.E.; Schuster, C.R.; Seiden, L.S. 1980: Amphetamine induces depletion of dopamine and loss of dopamine uptake sites in caudate Neurology 30(5): 547-550
Shahi, G.S.; Moochhala, S.M.; Das, N.P.; Sunamoto, J.; Tajima, K. 1990: The neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) induces changes in the heme spin state of microsomal cytochrome P-450 Biochemistry International 22(5): 895-901
Levitskaia, N.G.; Sebentsova, E.A.; Andreeva, L.A.; Alfeeva, L.I.; Kamenskiĭ, A.A.; Miasoedov, N.F. 2002: Neuroprotective effects of semax in MPTP-induced disturbances of brain dopamine system Rossiiskii Fiziologicheskii Zhurnal Imeni I.M. Sechenova 88(11): 1369-1377
Zhou, J.; Duan, L.-p.; Yang, X.-l.; Dong, X.-y.; Lin, S.-r. 2003: The roles of dopamine 4 receptor in MPTP-induced gastrointestinal mucosal injury in rats Zhonghua Yi Xue Za Zhi 83(18): 1611-1614
Fuller, R.W.; Hemrick-Luecke, S.K. 1987: Persistent depletion of striatal dopamine and its metabolites in mice by TMMP, an analogue of MPTP Journal of Pharmacy and Pharmacology 39(8): 667-669
Chen, S.D.; Zhou, X.D.; Xu, D.L.; Li, G.W.; Tang, Q.M.; Xu, X.R. 1991: Hemiparkinsonism in monkeys following unilateral common carotid artery infusion of MPTP. a study of behavior, biochemistry and histology Chinese Medical Journal 104(9): 758-763